Latest news
U.S. IPO Weekly Recap: August Kicks Off With Flurry Of Biotech IPOs - Seeking AlphaSeeking Alpha · Sat, 08 Aug 2026 04:30:00 GMTNon-opioid painkiller developer Latigo (LTGO.US) seeks to ride the biotech IPO “boom”! Issuance priced at $18 per share, aiming to raise $346 million - BitgetBitget · Fri, 07 Aug 2026 00:31:15 GMTAttovia, Braveheart and Vogenx seek more than $500M via IPOs - Fierce BiotechFierce Biotech · Thu, 30 Jul 2026 07:00:00 GMTBraveheart, Attovia and Vogenx seek $500M-plus in IPOs - AxiosAxios · Thu, 30 Jul 2026 07:00:00 GMT